Screening of Postpartum Depression in Egyptian Women

Postpartum Depression Clinical Trial

Official title:

Assessment of the Edinburgh Postnatal Depression Scale as Screening Tool for Postpartum Depression Among Women Delivering at Egyptian Tertiary Care System University Hospital: Prevalence and Risk Factors Analysis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05997953
• Other study ID #: 520235
• Status: Recruiting
• Start date: July 1, 2023
• Est. completion date: August 1, 2024

Study information

• Verified date: August 2023
• Source: Al-Azhar University
• Contact: Muhamed Alhagrasy, M.D.
• Phone: 01017313413
• Email: MuhamedAhmed.216[@]azhar.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this cross-sectional study is to assess the Edinburgh Postnatal Depression Scale as screening tool for Postpartum Depression among women delivering at Egyptian tertiary health care system, University Hospital, regarding Prevalence and risk factors.

participants of this study with fill the Edinburgh Postnatal Depression Scale and their socio-demographic, obstetric and psychological data will be collected and analysed.

prevalence of postpartum depression in Egyptian women will be assessed as well as the associated risk factors

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: August 1, 2024
• Est. primary completion date: June 1, 2024
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

All patients who underwent vaginal/cesarean delivery and reported for follow and willing to participate in the study.

Exclusion Criteria:

• Patients who were unwilling to participate in the study.

• Patients who are having difficulties comprehending the questionnaire of the study.

• Women who were on psychiatric medication during pregnancy.

Related Conditions & MeSH terms

• Depression
• Depression, Postpartum
• Depressive Disorder
• Postpartum Depression

Intervention

Other:
• Edinburgh Postnatal Depression Scale
Edinburgh Postnatal Depression Scale used as screening tool for postpartum depression

Locations

Country	Name	City	State
Egypt	Faculty od Medicine, Department of Obstetrics and Gynecology.	Cairo	Cairo.

Sponsors (1)

Lead Sponsor	Collaborator
Al-Azhar University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number screening positive for possible postpartum depression by Arabic EPDS	Number of participants screening positive for possible postpartum depression, defined as a score of 13 or higher on the validated Arabic version of the Edinburgh Postnatal Depression Scale (EPDS) Participants with a positive screen (EPDS score =13) will be referred for psychiatric consultation for diagnostic confirmation and treatment of postpartum depression	2 weeks postpartum
Secondary	Sociodemographic, clinical, and psychosocial predictors of postpartum depression risk	Identification of sociodemographic, clinical, and psychosocial risk factors associated with screening positive for possible postpartum depression, as determined by bivariate and multivariate regression analyses of factors correlated with an Arabic EPDS score =13.; Sociodemographic factors will include maternal age, education level, occupation, socioeconomic status, etc.; Clinical factors will include obstetric history, delivery method, neonatal health status, etc.; Psychosocial factors will include social support, stress levels, family dynamics, etc.	At 2 weeks postpartum